Revealed: Secret of HIV's natural born killers

June 10, 2012 in HIV & AIDS

Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

In a study they said holds promise for an , researchers from four countries reported the secret lies not in the number of infection-killing cells a person has, but in how well they work.

Only about one person in 300 has the ability to control the (HIV) without drugs, using a strain of "killer" cells called cytotoxic T lymphocyte (CTL) cells, previous research has found.

Taking that discovery further, scientists from the United States, Canada, Japan and Germany reported that the strain has molecules called receptors that are better able to identify HIV-infected for attack.

Until now, it was well known that people with HIV "have tonnes of these ," Bruce Walker, an infectious diseases expert at the Ragon Institute in Massachusetts, told AFP.

"We have been scratching our heads since then, asking how, with so many killer cells around, people are getting AIDS. It turns out there is a special quality that makes them (some cells) better at killing."

The study looked at 10 infected people, of whom five took to keep HIV under control while five were so-called elite controllers who remained naturally healthy.

HIV kills a type of white blood cell called CD4, leaving people with AIDS wide open to other, opportunistic and potentially .

"What we found was that the way the killer cells are able to see infected cells and engage them was different," said Walker.

"It is not just that you need a killer cell, what you need is a killer cell with a (T cell) receptor that is particularly good at recognising the infected cell. This gives us a way to understand what it is that makes a really good killer cell."

Walker said attempts at creating vaccines had so far failed because the T they generated were not the efficient type.

But while the research has showed scientists how to find and measure the good cells, they still do not yet know how to generate them.

"The next step is to determine what it is about those receptors that is endowing them with that ability," said Walker.

"HIV has revealed another one of its secrets and that is how the body is able to effectively control the virus in certain individuals.

"Each secret that HIV reveals is putting us in a better position to ultimately make a vaccine to control the virus."

More information: Nature Immunology, DOI: 10.1038/ni.2342

Journal reference: Nature Immunology search and more info website

(c) 2012 AFP

4.6 /5 (17 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

baudrunner
Jun 11, 2012

Rank: not rated yet
CD4 is a receptor site on a host cell. HIV needs two receptor sites to allow for entry into a host cell. The other is CCR5. In one percent of the population, the allele responsible for expressing CCR5 is mutant and non-functioning, therefore HIV replication cannot occur and the body's natural defenses rid the bloodstream of the virus. Pfizer has developed a CCR5 blocker that may be the best line of offense against progression of the disease, and to my knowledge it is currently undergoing clinical trial, a long and tedious process that normally takes years. Prepare for an anouncement sooner than later.
Rank 4.6 /5 (17 votes)
Relevant PhysicsForums posts

More news stories

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

HIV & AIDS created May 18, 2013 | popularity 5 / 5 (2) | comments 0

Peer-referral programs can increase HIV-testing in emergency departments

Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0

HIV no barrier to getting liver transplant, study finds

(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0

Twin epidemics: HIV and Hepatitis C in the urban Northeast

A new Yale study looks at the scope and consequences of a burgeoning health problem in the cities of the U.S. Northeast: concurrent infection with both HIV and Hepatitis C (HCV). The study appears online ...

HIV & AIDS created May 17, 2013 | popularity not rated yet | comments 0


New study finds blind people have the potential to use their 'inner bat' to locate objects

New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.

Researchers find far-reaching, microvascular damage in uninjured side of brain after stroke

While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a ...

Breakup of physician, drug company relationship could improve health care, cut cost

A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...

Food laboratory accuracy remains a concern

Food microbiology laboratories continue to submit false negative results and false positive results on a routine basis. A retrospective study of nearly 40,000 proficiency test results over the past 14 years, presented today ...

Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...

Which women should be screened for high cholesterol?

National guidelines recommend that at-risk women be screened for elevated cholesterol levels to reduce their chances of developing cardiovascular disease. But who is 'at risk?' The results of a study by investigators ...